Biovail Backs 2004 Earnings on Strong Sales Pharmaceutical firm Biovail Corp. on Tuesday narrowed the scope of its full-year revenue forecast to the middle of its prior estimate range, but backed its earnings prediction - excluding charges - of \$1.